Moderna sees shortfall in Britain COVID vaccine shipments, EU deliveries on track By Reuters
ZURICH (Reuters) - U.S. drugmaker Moderna (NASDAQ:MRNA) expects a shortfall in COVID-19 vaccine doses from its European supply chain hitting second-quarter delivery quantities for Britain and Canada, though European Union- and Swiss-bound shipments are on track, a spokesperson said. The delays, first announced on Friday when Canada said Moderna would be delivering only about half the planned 1.2 million doses by the end of April, come as Switzerland's Lonza ramps up three new production lines to make active ingredients for Moderna vaccine supplies outside of the United States. "The trajectory of vaccine manufacturing...
Continue reading